USPTO issues patent covering Probuphine for opiate addiction

Published June 18, 2010

USPTO issues patent covering Probuphine for opiate addiction
Titan Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued patent number 7,736,665 covering Probuphine for the treatment of opiate addiction.